IRIS
CAPUCCI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.735
EU - Europa 4.986
AS - Asia 3.582
SA - Sud America 949
AF - Africa 344
Continente sconosciuto - Info sul continente non disponibili 258
OC - Oceania 9
Totale 19.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.457
RU - Federazione Russa 1.393
SG - Singapore 1.176
VN - Vietnam 839
BR - Brasile 747
IT - Italia 702
UA - Ucraina 679
CN - Cina 538
DE - Germania 444
IE - Irlanda 402
SE - Svezia 299
FR - Francia 261
HK - Hong Kong 251
DK - Danimarca 220
TR - Turchia 198
GB - Regno Unito 192
FI - Finlandia 178
MA - Marocco 150
KR - Corea 119
CA - Canada 106
IN - India 102
CI - Costa d'Avorio 99
BD - Bangladesh 86
AR - Argentina 68
NL - Olanda 51
MX - Messico 48
IQ - Iraq 40
JP - Giappone 40
ZA - Sudafrica 35
EC - Ecuador 33
ES - Italia 33
PL - Polonia 33
CO - Colombia 29
CR - Costa Rica 25
ID - Indonesia 25
PK - Pakistan 25
VE - Venezuela 22
HN - Honduras 20
AT - Austria 19
BE - Belgio 19
PR - Porto Rico 16
TN - Tunisia 15
UZ - Uzbekistan 15
CL - Cile 13
GT - Guatemala 13
IL - Israele 13
JO - Giordania 13
EG - Egitto 12
EU - Europa 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
KZ - Kazakistan 11
PE - Perù 11
PH - Filippine 11
RS - Serbia 11
SA - Arabia Saudita 11
MY - Malesia 10
PY - Paraguay 10
RO - Romania 10
SV - El Salvador 10
CW - ???statistics.table.value.countryCode.CW??? 9
NI - Nicaragua 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
JM - Giamaica 7
AU - Australia 6
BO - Bolivia 6
DZ - Algeria 6
SN - Senegal 6
LB - Libano 5
NP - Nepal 5
BH - Bahrain 4
GP - Guadalupe 4
KE - Kenya 4
LT - Lituania 4
PT - Portogallo 4
SC - Seychelles 4
AZ - Azerbaigian 3
BG - Bulgaria 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
KW - Kuwait 2
NO - Norvegia 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 19.612
Salva come PNG Salva come JPEG
Città #
Ashburn 1.492
Singapore 749
Jacksonville 712
Chandler 664
Fairfield 556
Council Bluffs 436
Dublin 396
San Jose 379
Boardman 376
Dallas 341
New York 326
Ho Chi Minh City 261
Wilmington 245
Hong Kong 242
Seattle 216
Woodbridge 212
Houston 206
Hanoi 195
Cambridge 183
The Dalles 178
Beijing 156
Princeton 150
Lawrence 149
San Mateo 144
Los Angeles 143
Lauterbourg 142
Ann Arbor 116
Abidjan 99
Moscow 94
Hefei 90
Des Moines 84
Munich 75
San Diego 74
São Paulo 73
Milan 60
Turin 56
Chicago 55
London 49
Buffalo 47
Santa Clara 46
Ancona 44
Da Nang 44
Centro 40
Phoenix 37
Haiphong 34
Helsinki 34
Turku 34
Tokyo 33
Frankfurt am Main 32
Orem 32
Pune 31
Rome 30
Atlanta 29
Montreal 29
Miano 28
Warsaw 27
Washington 25
Belo Horizonte 24
Rio de Janeiro 24
Amsterdam 23
Denver 23
Brasília 22
Norwalk 22
Salt Lake City 22
Chennai 20
Toronto 20
Hải Dương 19
San José 19
Brussels 18
Johannesburg 18
Nuremberg 18
Baghdad 16
Poplar 16
Stockholm 16
Brooklyn 15
Salvador 15
Shanghai 15
Guangzhou 14
Mumbai 14
Porto 14
Amman 13
Tashkent 13
South Pasadena 12
Biên Hòa 11
Columbus 11
Guayaquil 11
Lahore 11
Manchester 11
Mexico City 11
Quảng Ngãi 11
Redmond 11
Vienna 11
Bogotá 10
Campinas 10
Can Tho 10
Curitiba 10
Destin 10
Guatemala City 10
Naples 10
San Francisco 10
Totale 11.474
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 853
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 281
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 235
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 193
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 179
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 172
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 171
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 169
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 168
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 163
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 160
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 160
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 159
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 158
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 154
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 153
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 152
Subclinical progression of systemic sclerosis-related cardiomyopathy 150
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 149
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments 147
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 146
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 144
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 143
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 143
Cardioembolism and takotsubo syndrome: A case report 142
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 141
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 140
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 139
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 137
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 137
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 136
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 135
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 135
New anthyarrhythmic drugs for atrial fibrillation 134
Dr. Guerra, et al reply 134
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 133
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 133
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 132
Subclinical atrial fibrillation and the risk of stroke 132
Takotsubo syndrome in the paediatric population: A case report and a systematic review 131
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 130
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 129
Safety and tolerability of a cardiologist-only approach to sedation for electrical cardioversion in the Emergency Department: The INSTEAD pilot trial 129
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 129
Temporal relationship between subclinical atrial fibrillation and embolic events 129
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 127
Antiarrhythmic drugs for atrial fibrillation. 127
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 127
Clinically guided pacemaker choice and setting: pacemaker expert programming study 126
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 125
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 125
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 124
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 123
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 123
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 123
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 122
Current Therapeutic Options for Heart Failure in Elderly Patients 122
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 122
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 122
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 121
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 121
Endocardial defibrillation lead extraction: an unusual case of entrapment. 120
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 120
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 120
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 119
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 119
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 119
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 117
Hospitalization in ICD recipients. 115
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 115
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 115
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 115
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 114
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 113
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 113
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 112
Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents 112
Electrical storm and heart failure worsening in implantable cardiac defibrillator patients 111
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 111
Out-of-hospital cardiac arrest and public access defibrillation. 111
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 111
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 111
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 111
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 110
Rebuttal of critique of Progetto Vita survival data 110
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 109
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 109
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. 108
Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet? 108
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 108
Emerging pharmacotherapies for the treatment of atrial fibrillation 108
Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance. 107
Indications for implantable cardioverter defibrillator (ICD) therapy. 107
Sedation in cardiac arrhythmias management 107
Symptomatic atrial fibrillation and risk of cardiovascular events: Data from the Euro Heart Survey 107
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 107
Cardiac regeneration by progenitor cells: what is it known as and what is it still to be known as? 106
Racial and Ethnic Differences in Electrocardiographic Features of Takotsubo Cardiomyopathy 106
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 106
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation 106
Totale 13.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022697 0 0 0 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20252.382 191 330 104 18 74 61 128 94 579 167 263 373
2025/20267.157 458 389 385 868 632 442 1.155 703 1.140 526 136 323
2026/20271.729 367 239 328 795 0 0 0 0 0 0 0 0
Totale 19.863